Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Rutgers Cancer Institute of New Jersey studying low participation in cancer screenings by South Asian population
In an effort to learn why South Asians in New Jersey and New York City have low participation rates when it comes to some cancer screenings, researchers at Rutgers Cancer Institute of New Jersey...
Merck announces data from pivotal Phase 3 fracture outcomes study for odanacatib, an investigational oral, once-weekly treatment for osteoporosis
Merck, known as MSD outside the United States and Canada, has announced data from the pivotal Phase 3 fracture outcomes study for odanacatib in postmenopausal women with osteoporosis.
New analyses of Phase 2 study show Romosozumab treatment resulted in continued increases in bone mineral density
UCB and Amgen have announced results from several exploratory analyses of the Phase 2 study evaluating romosozumab in postmenopausal women with low bone mineral density (BMD).
New data on the long-term efficacy and safety of Tresiba®  in children and adolescents with type 1 diabetes
During the 50th Annual Meeting of the European Association for the Study of Diabetes (EASD), Novo Nordisk announced new data from the BEGIN® YOUNG 1 trial.
Roche initiates phase III trials for lampalizumab, first potential treatment for geographic atrophy (GA)
Roche has announced that phase III clinical studies have been initiated for lampalizumab, an investigational drug for geographic atrophy (GA), the advanced form of age-related macular degeneration...
Large prospective randomized trial confirms clinical benefit of Embryoscope® time-lapse system
The success rate of assisted reproduction was significantly increased by the use of revolutionary time-lapse technologyA study accepted for publication in the renowned scientific journal...
Merck discontinues clinical development program of tecemotide as a monotherapy in Stage III non-small cell lung cancer
Merck has announced that its biopharmaceutical division Merck Serono will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide...
At four years, treatment effect maintained in more than two-thirds of patients who received Lemtrada in multiple sclerosis pivotal studies
Sanofi and its subsidiary Genzyme has announced positive interim results from the second year of the extension study of Lemtrada(TM) (alemtuzumab) for multiple sclerosis.
Data shows that nintedanib slowed lung function decline in patients independent of their lung function impairment at baseline
A pre-specified subgroup analysis from the two replicate Phase III INPULSIS™ trials, presented today in at the European Respiratory Society (ERS) International Congress in Munich, showed...
Phase III trials of pirfenidone show favourable and persistent treatment benefit on disease progression in patients with IDF up to 72 weeks
InterMune®, Inc. has presented the results of pooled analyses of data from three multinational, randomised phase III trials (ASCEND [Study 016] and CAPACITY [Studies 004 and 006]) that provide...
Poor recording of physical health and medication could be causing dementia trials to fail
Dementia trials could be failing because they all-too-often overlook the physical health of patients - according to new research from the University of East Anglia and Aston University.
Reanalyses of data from RCTs can lead to different conclusions
Although only a small number of reanalyses of data from randomized clinical trials (RCTs) have been published, an examination of those that have been conducted finds that about one-third led to...
Enzalutamide significantly reduces morbidities associated with bone metastases in men with metastatic castration-resistant prostate cancer
Enzalutamide (XTANDI™) reduces the risk of skeletal-related events compared with placebo, as well as reducing pain and increasing quality of life in men with metastatic castration-resistant...
MNK-155, an extended-release hydrocodone/acetaminophen combination, shows efficacy in Phase 3 acute pain trial
Mallinckrodt has reported that a Phase 3 efficacy trial of investigational MNK-155 met the study's primary endpoint of improved pain scores vs.
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2014
Content Management / Website Design by Tresware